Affective Disorders, Psychotic
14
1
1
12
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.1%
1 terminated out of 14 trials
92.3%
+5.8% vs benchmark
21%
3 trials in Phase 3/4
17%
2 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (14)
Arts-based Social Prescribing for Mental Health
Early Psychosis Intervention - Spreading Evidence-based Treatment
CBT-CP for Veterans With SMI
Assessment and Treatment for Chronic Pain in Veterans With Serious Mental Illness
Self-Management and Recovery Technology Psychosocial Intervention Trial
Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study
Treatment of Psychotic Major Depression With Mifepristone
Implementation of Illness Management and Recovery in Mental Health Services
Clinical Validation of the Rating Scale for Psychotic Depression (RAS-PD)
Smoking Cessation for Veterans With Severe and Persistent Mental Illness
Web-Based Weight Management for Individuals With Mental Illness
A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder
A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder
Routine Plasma Level Determination to Compare Actual vs Expected Plasma Levels at Psychiatric Inpatient Admission